Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and -resistant ovarian cancer cells

PURPOSE: Although paclitaxel is a promising first-line chemotherapeutic drug for ovarian cancer, acquired resistance to paclitaxel is one of the leading causes of treatment failure, limiting its clinical application. Asparagus officinalis has been shown to have anti-tumorigenic effects on cell growt...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, Wang, Jiandong, Fan, Yali, Zhao, Ziyi, Paraghamian, Sarah E., Hawkins, Gabrielle M., Buckingham, Lindsey, O’Donnell, Jillian, Hao, Tianran, Suo, Hongyan, Yin, Yajie, Sun, Wenchuan, Kong, Weimin, Sun, Delin, Zhao, Luyu, Zhou, Chunxiao, Bae-Jump, Victoria L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314877/
https://www.ncbi.nlm.nih.gov/pubmed/36006482
http://dx.doi.org/10.1007/s00432-022-04276-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314877/
https://www.ncbi.nlm.nih.gov/pubmed/36006482
http://dx.doi.org/10.1007/s00432-022-04276-8

Ejemplares similares